Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

Solventum, spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%.

The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 ...

Masimo (Nasdaq: MASI) shares fell after hours today on first-quarter results that beat the consensus forecast.

SS Innovations plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system.

Johnson & Johnson MedTech, Stryker and Zimmer Biomet lead MassDevice's annual list of the world's largest orthopedic device ...

Enovis beat earnings expectations in its first quarter 2025 results out today, but the market reaction was tempered.

GE HealthCare (Nasdaq: GEHC) announced today that it received FDA 510(k) clearance for its Aurora nuclear medicine system and ...

Bausch + Lomb announced today that it received CE mark approval for its LuxLife full range of vision intraocular lens (IOL).

German medtech giant Siemens Healthineers reduced the lower end of its full-year earnings guidance amid Trump administration ...

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.

Boston Scientific (NYSE: BSX) + Boston Scientific Corp. $104.068 0.15% Open 104.222 Day High 104.79 52 Week High 79.43 52 ...